IP Library Granted Patent US 11,241,014
Granted Patent B2
US 11,241,014 · App. 16/305,534 · Granted Feb 8, 2022

Antimicrobial coatings and methods of making and using thereof

Inventors: M. G. Finn (Atlanta, GA); Jennifer Marie Beveridge (Atlanta, GA); Allison Geoghan Aioub (Atlanta, GA); Zhishuai Geng (Atlanta, GA)
Assignee: Georgia Tech Research Corporation
A01N43/90A01N25/10A01N43/40A01N43/46C07D495/08C09D5/14C08F8/32C08F120/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,241,014
App. No.
16/305,534
Granted
Feb 8, 2022
Kind
B2
Abstract

Disclosed are antimicrobial articles and surfaces, as well as methods of making such articles and surfaces.

Claims (51)

1. A process for rendering a polyvinyl chloride surface antimicrobial, the process comprising:

(a) flowing an aqueous solution comprising an azidation reagent and a phase transfer catalyst across the polyvinyl chloride surface to form an azide-substituted polyvinyl chloride; and

(b) contacting the azide-substituted polyvinyl chloride with an antimicrobial agent comprising an alkyne moiety under conditions effective to covalently bond the antimicrobial agent to the polyvinyl chloride surface.

2. The process of claim 1 , wherein step (a) comprises contacting the polyvinyl chloride with the azidation reagent and the phase transfer catalyst for 3 hours or less.

3. The process of claim 1 , wherein the alkyne moiety is activated by ring strain, electron withdrawing groups, or a combination thereof.

4. The process of claim 1 , wherein step (b) comprises contacting the azide-substituted polyvinyl chloride with the antimicrobial agent comprising the alkyne moiety in the presence of a Cu(I) catalyst.

5. The process of claim 1 , wherein the polyvinyl chloride surface comprises a surface of a medical article.

6. The process of claim 5 , wherein the medical article comprises tubing, and wherein the surface of the medical article comprises an interior surface of the tubing, an exterior surface of the tubing, or both an interior surface of the tubing and an exterior surface of the tubing.

7. The process of claim 1 , wherein the antimicrobial agent comprises a polycationic polymer.

8. The process of claim 7 , wherein the polycationic polymer comprises a polymer defined by Formula I below

wherein

Z represents, individually for each occurrence, S, Se, or NR 3 ;

A represents, individually for each occurrence, a heterocyclic ring comprising a cationic nitrogen center;

X represents, individually for each occurrence, an anion;

Y is absent, or represents, individually for each occurrence, a linking group;

R 1 is absent, or represents, individually for each occurrence, halogen, hydroxy, amino, cyano, azido, hydrazone, alkyl, alkenyl, alkynyl, alkoxy, aryl, heteroaryl, alkylaryl, alkylheteroaryl, cycloalkyl alkylcycloalkyl, heterocycloalkyl, alkylheterocycloalkyl, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, dialkylamino, alkylcarbonyl, alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, peptidyl, polyamino, or polyalkyleneoxy;

R 2 is absent, or represents, individually for each occurrence, alkyl, alkenyl, alkynyl, alkoxy, aryl, heteroaryl, alkylaryl, alkylheteroaryl, cycloalkyl alkylcycloalkyl, heterocycloalkyl, alkylheterocycloalkyl, peptidyl, polyamino, or polyalkyleneoxy;

R 3 represents, individually for each occurrence, alkyl, alkenyl, alkynyl, alkoxy, aryl, heteroaryl, alkylaryl, alkylheteroaryl, cycloalkyl alkylcycloalkyl, heterocycloalkyl, alkylheterocycloalkyl, peptidyl, polyamino, or polyalkyleneoxy; and

n is an integer from 2 to 400,

wherein at least one of R 1 , R 2 , or R 3 comprises an alkynyl group.

9. The process of claim 8 , A is chosen from pyridine, imidazole, pyrazole, triazole, tetrazole, oxazole, isoxazole, furazan, isothioazole, and thiazole.

10. The process of claim 8 , wherein Z is S.

11. The process of claim 8 , wherein Z is NR 3 .

12. The process of claim 8 , wherein R 1 , R 2 , R 3 , or a combination thereof comprise a cationic moiety.

13. The process of claim 8 , wherein R 1 comprise an alkynyl group.

14. The process of claim 8 , wherein R 2 comprises an alkynyl group.

15. The process of claim 8 , wherein Y is chosen from one of the following:

where m is an integer from 1 to 12.

16. The process of claim 8 , wherein the polycationic polymer comprises a polymer defined by Formula IA below

wherein Z, X, Y, R 1 , R 2 , R 3 , and n are as defined above with respect to Formula I.

17. The process of claim 7 , wherein the polycationic polymer comprises a recurring unit defined by Formula V below

wherein

R 4 represents H or methyl;

L is absent or represents a linking group;

A represents, individually for each occurrence, a heterocyclic ring comprising a cationic nitrogen center;

R 5 is absent, or represents, individually for each occurrence, halogen, hydroxy, amino, cyano, azido, hydrazone, alkyl, alkenyl, alkynyl, alkoxy, aryl, heteroaryl, alkylaryl, alkylheteroaryl, cycloalkyl alkylcycloalkyl, heterocycloalkyl, alkylheterocycloalkyl, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, dialkylamino, alkylcarbonyl, alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, peptidyl, polyamino, or polyalkyleneoxy; and

m is an integer from 0 to 5.

18. A process for rendering a polyvinyl chloride surface antimicrobial, the process comprising:

(a) contacting the polyvinyl chloride with an azidation reagent in the presence of a phase transfer catalyst to form an azide-substituted polyvinyl chloride; and

(b) contacting the azide-substituted polyvinyl chloride with an antimicrobial agent comprising an alkyne moiety under conditions effective to covalently bond the antimicrobial agent to the polyvinyl chloride surface;

wherein the wherein the antimicrobial agent comprises a polycationic polymer defined by Formula I below

wherein

Z represents, individually for each occurrence, S, Se, or NR 3 ;

A represents, individually for each occurrence, a heterocyclic ring comprising a cationic nitrogen center;

X represents, individually for each occurrence, an anion;

Y is absent, or represents, individually for each occurrence, a linking group;

R 1 is absent, or represents, individually for each occurrence, halogen, hydroxy, amino, cyano, azido, hydrazone, alkyl, alkenyl, alkynyl, alkoxy, aryl, heteroaryl, alkylaryl, alkylheteroaryl, cycloalkyl alkylcycloalkyl, heterocycloalkyl, alkylheterocycloalkyl, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, dialkylamino, alkylcarbonyl, alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, peptidyl, polyamino, or polyalkyleneoxy;

R 2 is absent, or represents, individually for each occurrence, alkyl, alkenyl, alkynyl, alkoxy, aryl, heteroaryl, alkylaryl, alkylheteroaryl, cycloalkyl alkylcycloalkyl, heterocycloalkyl, alkylheterocycloalkyl, peptidyl, polyamino, or polyalkyleneoxy;

R 3 represents, individually for each occurrence, alkyl, alkenyl, alkynyl, alkoxy, aryl, heteroaryl, alkylaryl, alkylheteroaryl, cycloalkyl alkylcycloalkyl, heterocycloalkyl, alkylheterocycloalkyl, peptidyl, polyamino, or polyalkyleneoxy; and

n is an integer from 2 to 400,

wherein at least one of R 1 , R 2 , or R 3 comprises an alkynyl group.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 5, 2025
From: GEORGIA INSTITUTE OF TECHNOLOGY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 070412/0628 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2020
From: FINN, M.G.; BEVERIDGE, JENNIFER MARIE; AIOUB, ALLISON GEOGHAN; GENG, ZHISHUAI
To: GEORGIA TECH RESEARCH CORPORATION
Reel/Frame 052081/0268 →
Continuity (3)
Provisional Application 62343317 · May 31, 2016
Provisional Application 62393684 · Sep 13, 2016
Related Publication 20200281205A1 · Sep 10, 2020